Results per Page:
The Beam: Understanding liver, gastrointestinal and breast cancer treatments at Fred Hutch – Proton Therapy
Drs. Smith Apisarnthanarax and Kylie Kang talk about the latest updates in these cancers and explain the importance of proton therapy when treating these areas
Mitochondrial minerals and metabolic manipulation
From the Sancak Lab, University of Washington
Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium
Making the most of a small supply
Fred Hutch researchers receive $1.3 million grant from the U.S. Department of Defense to study the fundamental biology of five rare liver cancers that could lead to new treatments one day
Finding a rare bile duct cancer’s weaknesses
DOD and Cholangiocarcinoma Foundation awards will help Dr. Debraj Boila reveal genetics, drug targets of intrahepatic cholangiocarcinoma
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Mapping a pathway to hope
How Fred Hutch researchers revealed the biology behind a drug’s success in a rare liver cancer and paired it with another drug for a one-two punch
Michael Mendiola almost gave up – until he talked to “Dr. A”
“I recommended proton therapy both times for Mr. Mendiola because he had multiple prior treatments to the liver,” says Apisarnthanarax.
Liver cancer researcher Dr. Abir Arfaoui named latest Brave Fellow
Running community honors late athlete Gabe Grunewald by funding rare cancer research at Fred Hutch
Cancer-busting broccoli sprout pills? It’s a thing.
Translational scientist’s ‘green chemoprevention’ research extends from eastern China to Seattle and now, into space
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Shifting liver cancer cells away from migratory state could reduce their drug resistance
Researchers hope lab-based study helps build foundation for personalized treatment of hepatocellular carcinoma
Mourning Dr. Supriya 'Shoop' Saha, rising star in liver cancer research
'Truly gifted' physician-scientist made lasting impact in cholangiocarcinoma
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Good News: 8 Fred Hutch/UW researchers receive pilot awards
Celebrating faculty and staff achievements